Basilea Pharmaceutica’s CHF 75 Million Senior Secured Loan Agreement with Athyrium

Federica Tiefenthaler
Tagged:

BianchiSchwald advised Athyrium on the deal.The listed company Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company entered into a senior secured loan agreement with funds…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here